Related Experiment Video
Updated: Jul 27, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Differentiation of the Cytokine Profile Modified by SARS-CoV-2 and Influenza Virus in an In Vitro Experiment
N V Zaitseva1, K G Starkova1, O V Dolgikh2
1Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Perm, Russia.
We compared changes in the expression of the cytokine profile modified by SARS-CoV-2 and influenza virus in an in vitro experiment. A mixed population of immunocytes (T-helpers, B cells, NK cells, cytotoxic T lymphocytes, and monocytes) was isolated from peripheral venous blood samples (n = 32) of conditionally healthy male donors aged 25-35 years. The modifying factors were recombinant adenovirus particles of 26 and 5 serotypes containing the gene encoding S protein of SARS-CoV-2, as well as vaccine antigens (hemagglutinins) of influenza virus type A (H1N1 and H2N3) and type B. Multidirectional changes in the cytokine production was revealed upon exposure to SARS-CoV-2 antigens: stimulation of the expression of IL-1β and IL-8 and suppression of the production of IL-4 and IL-6; changes in the expression of IL-8 and IL-6 were more pronounced after combined exposure (SARS-CoV-2 + influenza virus). Influenza virus antigens predominantly stimulated the expression (IL-8), while the maximum cytokine-producing effects were noted after combined exposure to SARS-CoV-2 and influenza virus antigens. The obtained results extend the understanding of the pathogenic mechanisms associated with persistence of SARS-CoV-2 and influenza virus. The modifications of the cytokine profile produced by the viruses and verified in vitro allow predicting and monitoring the course of diseases.
We compared changes in the expression of the cytokine profile modified by SARS-CoV-2 and influenza virus in an in vitro experiment. A mixed population of immunocytes (T-helpers, B cells, NK cells, cytotoxic T lymphocytes, and monocytes) was isolated from peripheral venous blood samples (n = 32) of conditionally healthy male donors aged 25-35 years. The modifying factors were recombinant adenovirus particles of 26 and 5 serotypes containing the gene encoding S protein of SARS-CoV-2, as well as vaccine antigens (hemagglutinins) of influenza virus type A (H1N1 and H2N3) and type B. Multidirectional changes in the cytokine production was revealed upon exposure to SARS-CoV-2 antigens: stimulation of the expression of IL-1β and IL-8 and suppression of the production of IL-4 and IL-6; changes in the expression of IL-8 and IL-6 were more pronounced after combined exposure (SARS-CoV-2 + influenza virus). Influenza virus antigens predominantly stimulated the expression (IL-8), while the maximum cytokine-producing effects were noted after combined exposure to SARS-CoV-2 and influenza virus antigens. The obtained results extend the understanding of the pathogenic mechanisms associated with persistence of SARS-CoV-2 and influenza virus. The modifications of the cytokine profile produced by the viruses and verified in vitro allow predicting and monitoring the course of diseases.
More Related Videos
Related Concept Videos
Viral Recombination
Viral Mutations
Leaky Scanning
Viruses with RNA Genomes
Coronavirus

